Sensorion’s SENS-401 Reduces Hearing Loss in Preclinical Study When Oral Administration Initiated Up to Four Days after Acoustic Trauma. pdfRead

Sensorion confirme son éligibilité au dispositif PEA-PME. pdfLire

Sensorion reports full year 2017 results. pdfRead

Sensorion to present Data in Two Oral Sessions at the American Neurotology Society’s 2018 Spring Meeting. pdfRead

Sensorion Presents New SENS-401 Data at ARO 2018 MidWinter Meeting. pdfRead

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events